The University of Health Sciences Antigua (UHSA) has partnered with Toronto-based Revive Therapeutics (CSE:RVV, USA:RVVTF) to research the potential of psilocybin to help those with addiction. Revive’s focus has increased following its 2020 acquisition of Psilocin Pharma Corp.
University of Health Sciences Antigua is currently in the process of obtaining permits to import psilocybin for translational research, according to Dr. Manuel Flores, a professor at the University of Health Sciences Antigua. “We’re in the preliminary phases right now,” he said.
The university intends to focus on exploring the “lighter side of the benefits of psilocybin since the island is still new to it,” said Dr. Adedayo Akande, president of UHSA. “We decided to do a proposal study for investigating the therapeutic potential of psilocybin for alcohol dependence,” Akande notes.